Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Leukemia; Leukemia, Myeloid, Acute Phase 1/Phase 2 ClinicalTrials
CONTENTS